PILL.CN - Canntab Therapeutics Limited

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 528.95M
Enterprise Value 322.39M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)90.94
Price/Book (mrq)8.07
Enterprise Value/Revenue 370.32
Enterprise Value/EBITDA 6-11.40

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 316.44%
S&P500 52-Week Change 35.46%
52 Week High 30.9400
52 Week Low 30.2700
50-Day Moving Average 30.6647
200-Day Moving Average 30.5162

Share Statistics

Avg Vol (3 month) 323.93k
Avg Vol (10 day) 337.24k
Shares Outstanding 531.47M
Float 32.68M
% Held by Insiders 111.84%
% Held by Institutions 10.00%
Shares Short (Apr. 14, 2020) 4562
Short Ratio (Apr. 14, 2020) 40.01
Short % of Float (Apr. 14, 2020) 4N/A
Short % of Shares Outstanding (Apr. 14, 2020) 40.00%
Shares Short (prior month Mar. 12, 2020) 410.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar. 07, 2016
Last Split Factor 21:200
Last Split Date 3Apr. 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2019
Most Recent Quarter (mrq)Feb. 28, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-652.54%

Management Effectiveness

Return on Assets (ttm)-33.49%
Return on Equity (ttm)-72.73%

Income Statement

Revenue (ttm)318.33k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)143.61k
EBITDA -1.96M
Net Income Avi to Common (ttm)-2.28M
Diluted EPS (ttm)-0.0860
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.5M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)297.47k
Total Debt/Equity (mrq)8.30
Current Ratio (mrq)3.91
Book Value Per Share (mrq)0.11

Cash Flow Statement

Operating Cash Flow (ttm)-1.59M
Levered Free Cash Flow (ttm)-2.59M